Design Therapeutics Picks Up $125M For Small Molecules
socalTECH
JANUARY 27, 2021
San Diego-based Design Therapeutics, a biotech company which is developing small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions, said it has raised $125M in its Series B funding round. Rowe Price Associates, Inc., Arsani William, M.D.,
Let's personalize your content